YORK, Pa., Nov. 25, 2014 /PRNewswire/ -- Unilife Corporation (NASDAQ:UNIS, ASX: UNS), a designer, manufacturer and supplier of injectable drug delivery systems, today announced that its Chairman and CEO, Alan Shortall, is scheduled to present at the Piper Jaffray 26th Annual Healthcare Conference at the New York Palace Hotel at 8:30 a.m. EST on Tuesday, December 2, 2014.
The conference presentation will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of the event will also be available for those unable to listen live.
About Unilife Corporation
Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's portfolio of innovative, differentiated products includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and novel systems. Products within each platform are customizable to address specific customer, drug and patient requirements. Unilife's global headquarters and manufacturing facilities are located in York, PA. For more information, visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.
General: UNIS-G
|
Investor / PR Contacts (US):
|
Analyst Enquiries:
|
Investor Contacts (Australia):
|
|
Todd Fromer / Garth Russell
|
Leigh Salvo
|
Jeff Carter
|
|
KCSA Strategic Communications
|
Westwicke Partners
|
Unilife Corporation
|
|
P: + 1 212-682-6300
|
P: + 1 415-513-1281
|
P: + 61 2 8346 6500
|
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/unilife-to-present-at-the-piper-jaffray-26th-annual-healthcare-conference-on-december-2nd-300001227.html
SOURCE Unilife Corporation
